A Phase 1 Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of Subcutaneous KK3910 Compared with Placebo in Healthy Volunteers and Patients with Essential Hypertension

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2025
This article has no abstract
Epistemonikos ID: 2e7fe92032f3db2314926081f587a64ab8b74d9d
First added on: Apr 22, 2026